top of page
News, Events and Updates
Search
Anavex Management to Hold Live Investor Conference Call Today at 4:30PM ET
Mar 16, 2011
Anavex Receives Approval to Commence Phase I Clinical Trial in Alzheimer’s Disease
Mar 15, 2011
Anavex Appoints Dr. Jeffrey Cummings to its Scientific Advisory Board
Mar 1, 2011
Anavex Appoints Independent Director
Feb 24, 2011
Anavex Appoints Dr. Rachelle Doody to Scientific Advisory Board
Feb 23, 2011
Anavex Adds Dr. Paul Aisen to Scientific Advisory Board
Feb 16, 2011
Anavex Comments on President Obama’s Signing of National Alzheimer’s Project Act into Law
Jan 18, 2011
Alzheimer’s Weekly Names ANAVEX 2-73 the Number One Most Promising Trial Drug in Alzheimer’s Disease
Jan 6, 2011
Anavex Files Phase I Regulatory Submission for ANAVEX 2-73 in Alzheimer’s Disease
Dec 21, 2010
Anavex Appoints David Tousley as CFO
Sep 30, 2010
ANAVEX 2-73: Journal of Psychopharmacology Publishes Anti-Amnesic and Neuroprotective Data
Sep 13, 2010
44
45
46
47
48
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
